A pharmaceutical company has voluntarily recalled three specific batches of epinephrine injections, USP 30 mg/30 mL, due to concerns about sterility and the possible presence of particulate matter. American Regent, the company behind the product, initiated the nationwide recall after customers reported issues such as "leaking and cracked vials," as noted in a notice from the U.S. Food and Drug Administration (FDA). The FDA plays a key role in ensuring the safety and effectiveness of prescription drugs in the United States. During its investigation, American Regent found that the epinephrine injections contained various types of particulate matter, including materials like Nylon, Cellulosic, Acrylic, Polyethylene, and Glass. These particles are not supposed to be present in injectable medications, as they can cause serious health risks. Epinephrine is a critical medication used to treat severe allergic reactions, known as anaphylaxis, and to increase blood pressure in adults during emergencies. The FDA has issued a warning that if the medication containing these particles is administered intravenously—directly into the bloodstream—it could lead to serious, potentially life-threatening health consequences. These may include the formation of blood clots, permanent damage to organs, or even death. Additionally, cracked vials can compromise the sterility of the medication, increasing the risk of contamination and further endangering patients. American Regent is currently informing distributors and customers about the recall through mailed notices. Consumers, retailers, and healthcare facilities are being advised to stop using the affected product immediately and either return it or dispose of it properly. As of now, the company has not received any reports of adverse events linked to this recall. For those with questions or concerns, American Regent can be contacted at 1-800-645-1706, Monday through Friday during regular business hours.